Ikena Oncology, Inc. is a targeted precision oncology company headquartered in Boston, Massachusetts, United States, focused on developing breakthrough therapeutics.
Subscribe to see Ikena Oncology, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Ikena Oncology, Inc. is a company headquartered in Boston, United States. Its most recent funding round raised $75M in July 2025. Xcout tracks 11 named people at Ikena Oncology, Inc., including Jotin Marango (CFO, COO and Head of Corporate Development).
As of 16 November 2026. Source: Xcout Intel.
5 more named people on record for Ikena Oncology, Inc., with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $75M | — | |
| SEC Form D filing | $42.6M | — | |
| Series B | $120M | 1 named | |
| Venture Round | $80M | 1 named | |
| — | Undisclosed | 12 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A funding-flow diagram of the 14 named investors across 3 rounds: who backed which round, who led it, and who came back for the next one.
Sign in to see it, or subscribe for the full funding history →
A few of Ikena Oncology, Inc.'s closest competitors — see the full list of competitors and alternatives →
Elevation Oncology, Inc. is an innovative oncology company focused on discovering and developing targeted therapies for cancer, with corporate locations in Boston and New York.
Carrick Therapeutics is a biopharmaceutical company with its corporate headquarters located in Boston, Massachusetts, focused on discovering and developing innovative cancer treatments.
Jnana Therapeutics Inc. is a precision medicine company headquartered in Boston, Massachusetts, launched in 2017 to develop novel therapeutics.
Kinaset Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in Boston, Massachusetts, focused on developing novel therapeutics.
OncXerna Therapeutics is a clinical-stage precision-oncology biotechnology company that develops RNA-based biomarkers and targeted cancer therapies. Its work is intended to help identify cancer patients most likely to benefit from particular treatments and support oncologists and pharmaceutical partners in treatment selection.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Ikena Oncology, Inc.? Suggest a correction · Work at Ikena Oncology, Inc.? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.